Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Eir
  6. /
  7. Baxter Oncology GmbH
EIR
•Baxter Oncology GmbH•August 27, 2024

Baxter Oncology GmbH – FDA EIR, Aug 27, 2024

Record Details

An FDA inspection of Baxter Oncology GmbH, located in Halle (Westf.), Germany, was conducted from August 19 to August 27, 2024. The inspection, carried out by CDER/OP, focused on the company's drug product manufacturing processes, including quality, facility and equipment, production, material, and laboratory systems.At the conclusion of the inspection, a 6-item Form FDA 483 was issued, highlighting several significant observations. Key issues included a failure to establish adequate process, procedural controls, and testing to ensure drug product identity, strength, quality, and purity. Deficiencies were also noted regarding the unavailability of calibration specifications for drug product manufacturing, unclear drug substance storage requirements, and an inadequate validation process. Furthermore, standard operating procedures for drug product manufacturing were found to be either deficient or not followed, and facilities and equipment were not adequately maintained.These observations indicate a need for the firm to enhance its adherence to Good Manufacturing Practices (GMP). The final district decision was "Voluntary Action Indicated (VAI)," meaning Baxter Oncology GmbH is expected to address these deficiencies proactively to ensure compliance with regulatory standards for drug product manufacturing.

Company
Baxter Oncology GmbH
Inspection date
August 27, 2024
Product type
drugs
Office
Office of Pharmaceutical Quality Operations
People
  • Jeanne M. Fringer (other)
  • Wayne E. Seifert (Senior Regulatory Specialist)
View Company Profile

ID · 926cf150-be1f-4e3c-8bcc-c1595173865d

Other documents for Baxter Oncology GmbH
  • 483 - 2025-09-26September 26, 2025
  • 483 - 2024-08-27August 27, 2024
  • 483 - 2019-11-05November 5, 2019
  • 483 - 2018-08-20August 20, 2018
  • 483 - 2018-06-14June 14, 2018

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Baxter Oncology GmbH
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.